ASAM Provider Guide

National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1224390

Contents of this Issue

Navigation

Page 19 of 29

20 Treatment Figure 1. Evaluation and Treatment Physical History • Concomitant medical conditions (hepatitis, HIV, TB, acute trauma, pregnancy) • Other substance use including tobacco • Offer hepatitis B vaccine (?) • Offer contraception (?) • Withdrawal management (WM) Laboratory • CBC, LFTs, HIV, hepatitis A, B & C • Urine drug testing (frequently) • STDs(?) • Pregnancy(?) Social and Environmental Factors Select treatment site Identify and refer urgent problems LEGEND Diagnosis/Evaluation Treatment Results, Notes, Status Important Comments Consider medications for OUD Consider medications for WM Consider psychosocial treatment needs • Buprenorphine • Methadone • Lofexidine • Clonidine • Other ancillary meds Initiate Treatment • Buprenorphine • Methadone • XTR-Naltrexone • Counseling • Relapse Prevention • Food insecurity • Housing • Transportation • Interpersonal violence Level 1: Outpatient/ primary care Level 2: Intensive outpatient/PHP Level 3: Residential Level 4: Hospital Consider Overdose Prevention (See Naloxone Recommendations) Medication Management Monitoring Relapse Risk Progress and Outcome Monitoring Ongoing Treatment and Monitoring Adjust treatment plan as needed: • Medication dose • Psychosocial services • Recovery support services • Level of Care/Treatment site • Switch medications? Mental Health Status • (See Co-Occurring Psychiatric Disorders)

Articles in this issue

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update